Home pageEKSO • NASDAQ
add
Ekso Bionics Holdings Inc
Chiusura precedente
0,67 $
Intervallo giornaliero
0,66 $ - 0,70 $
Intervallo annuale
0,66 $ - 3,13 $
Cap di mercato
15,00 Mln USD
Volume medio
99.753,00
Rapporto P/E
-
Dividendo/Prezzo
-
Borsa valori principale
NASDAQ
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
(USD) | set 2024info | Variazione Y/Y |
---|---|---|
Entrate | 4,13 Mln | -10,38% |
Spese di gestione | 4,85 Mln | -10,01% |
Utile netto | -2,07 Mln | 38,42% |
Margine di profitto netto | -50,18 | 31,30% |
Utili per azione | — | — |
EBITDA | -2,23 Mln | 10,97% |
Aliquota fiscale effettiva | — | — |
Stato patrimoniale
Totale attivo
Totale passivo
(USD) | set 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 8,29 Mln | -16,55% |
Totale attivo | 29,21 Mln | -6,33% |
Totale passivo | 14,34 Mln | -9,96% |
Patrimonio netto totale | 14,87 Mln | — |
Azioni in circolazione | 22,00 Mln | — |
Prezzo/valore contabile | 0,99 | — |
Redditività dell'attivo | -23,48% | — |
Rendimento sul capitale | -33,02% | — |
Flusso di cassa
Flusso di cassa netto
(USD) | set 2024info | Variazione Y/Y |
---|---|---|
Utile netto | -2,07 Mln | 38,42% |
Liquidità di esercizio | -2,28 Mln | 32,09% |
Contanti da investimenti | -8000,00 | 52,94% |
Contanti da finanziamenti | 4,69 Mln | — |
Flusso di cassa netto | 2,41 Mln | 171,42% |
Flusso di cassa libero | -1,11 Mln | 57,80% |
Informazioni
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
CEO
Fondazione
2005
Sito web
Dipendenti
70